X-linked Agammaglobulinemia

Cardiovascular·MeSH: Common Variable Immunodeficiency

Prevalence

0.5 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target X-linked Agammaglobulinemia?

There are 1 clinical trial targeting X-linked Agammaglobulinemia tracked by BioSniper.

What is the prevalence of X-linked Agammaglobulinemia?

The estimated prevalence of X-linked Agammaglobulinemia is approximately 0.5 per 100,000 population.

Deep-dive into X-linked Agammaglobulinemia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    X-linked Agammaglobulinemia — Drugs in Development & Clinical Trials | BioSniper